Status:
COMPLETED
Home Centered Comprehensive Care (HCCC) for Children With Asthma
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborating Sponsors:
Centers for Medicare and Medicaid Services
National Institutes of Health (NIH)
Conditions:
Asthma
Eligibility:
All Genders
2-18 years
Phase:
NA
Brief Summary
The purpose of this study is to assess whether comprehensive care enhanced with new technology to optimize asthma care in the home (using both a special sensor to track inhaler use and a hand-held PIK...
Detailed Description
BACKGROUND INFORMATION Asthma is the most common pediatric chronic disease. Despite the understanding of its pathophysiology and the availability of effective therapies, adverse effects on health, sc...
Eligibility Criteria
Inclusion
- Children with severe asthma (poorly controlled by NIH guidelines ) who meet the inclusion criteria for HRCC (\>3 ED visits, \>2 hospitalizations, or \>1 pediatric ICU admission in past as well as a \>50% estimated risk of hospitalization in next yr).
Exclusion
- other major lung disease (e.g. cystic fibrosis or bronchopulmonary dysplasia) or neuromuscular impairment.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2017
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT02256397
Start Date
October 1 2014
End Date
April 1 2017
Last Update
May 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
High Risk Children's Clinic
Houston, Texas, United States, 77030